NIH

In May 2023, ASHG hosted a third year of virtual advocacy meetings with policymakers on Capitol Hill. The week-long event brought together trainee advocates from both the 2022 and the 2023 Advocacy Certificate for Human Genetics and Genomics Trainees (ACGT) program. Participation in this spring advocacy activity is a key feature of the ACGT program.... Read More

In May 2023, ASHG hosted its third year of virtual advocacy meetings on Capitol Hill. Both current and several former trainee advocates from the Advocacy Certificate for Human Genetics and Genomics Trainees (ACGT) program participated in this week-long advocacy activity. The ACGT program was launched as part of ASHG’s Government & Public Advocacy Committee (GPAC)... Read More

November 8 saw a midterm election during which all members of the House of Representatives and one-third of the Senate were up for re-election. Democrats retained control of the Senate and Republicans ultimately won only a narrow majority in the House. This will usher in at least two years of divided government, and experts anticipate... Read More

For Immediate Release: Thursday, November 10, 2022, 10:00 a.m. U.S. Eastern Time Media Contact: Kara Flynn, (202) 257-8424,  press@ashg.org ROCKVILLE, MD –The American Society of Human Genetics (ASHG) today released the Human Genetics & Genomics Workforce Survey Report, which takes an in-depth look at the field’s workforce demographics, including race, ethnicity, or ancestry; gender identity; sexual... Read More

The biomedical research system has historically been supported by two main pillars: fundamental research on the mechanisms of disease, largely funded by the National Institutes of Health (NIH), and the pharmaceutical industry, which creates products to treat these conditions. Recent advances in biomedical research and health sciences present an opportunity to change how we understand,... Read More